Health
Androgen deprivation therapy, death among patients with prostate cancer, COVID-19 – EurekAlert
What The Study Did: The findings from this study that included more than 1,100 patients with prostate cancer found no statistically…
What The Study Did: The findings from this study that included more than 1,100 patients with prostate cancer found no statistically significant difference in the rates of 30-day mortality from any cause following COVID-19 infection among men receiving androgen…
Continue Reading
-
Business8 hours agoMacquarie tips 60%+ return for this ASX All Ords stock
-
General8 hours agoOverheated share markets may risk financial meltdown
-
Business10 hours agoWhere will the CBA share price go next? Here’s what the experts say
-
Business11 hours agoWhy Morgans upgraded TPG, ANZ Bank, and this ASX share